Antibiotic resistance of Acinetobacter Baumanii isolated from children in Wuhan between 2006 and 2008

YU Tao, BAO Lian-Sheng, YANG Lao-Rong, LIU Fang

Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (08) : 613-615.

PDF(960 KB)
PDF(960 KB)
Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (08) : 613-615.
CLINICAL RESEARCH

Antibiotic resistance of Acinetobacter Baumanii isolated from children in Wuhan between 2006 and 2008

  • YU Tao, BAO Lian-Sheng, YANG Lao-Rong, LIU Fang
Author information +
History +

Abstract

OBJECTIVE: To investigate the variance of antibiotic resistance of Acinetobacter Baumanii isolated from children in Wuhan between 2006 and 2008. METHODS: Bacterial susceptibility testing was carried out by the Kirby-Bauer method in 679 strains of Acinetobacter Baumanii isolated in Wuhan Children’s Hospital between 2006 and 2008. The results were assessed according to the guidelines of the Clinical and Laboratory Standards Institute (2008). RESULTS: The nonsusceptible rates of Acinetobacter Baumanii to ceftazidime, cefepime and piperacillin/sulbactam increased significantly in 2007 compared with those in 2006 (P<0.05). By comparing the results of 2007, it was suggested that the nonsusceptible rates of Acinetobacter Baumanii to ceftazidime, cefepime, piperacillin/sulbactam, cefoperazone/sulbactam, imipenem and meropenem increased significantly in 2008 (P<0.05). CONCLUSIONS: The nonsusceptible rates of Acinetobacter Baumanii to β-lactam antibiotics in children from Wuhan increased significantly year by year between 2006 and 2008.[Chin J Contemp Pediatr, 2010, 12 (8):613-615]

Key words

Acinetobacter Baumanii / Antibiotic resistance / Child

Cite this article

Download Citations
YU Tao, BAO Lian-Sheng, YANG Lao-Rong, LIU Fang. Antibiotic resistance of Acinetobacter Baumanii isolated from children in Wuhan between 2006 and 2008[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(08): 613-615

References

[1]Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21 (3):538-582.
[2]Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology[J].Clin Microbiol Infec, 2006, 12(9):826-836.
[3]Pauline DM, Laurent P, Patrice N. Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii[J]. J Bacteriol, 2009,191(7):2414-2418.
[4]Livermore DM, Hill RL, Thomson H, Charlett A, Turton JF, Pike R, et al. Antimicrobial treatment and clinical outcome for infections with carbapenem-and multiply-resistant Acinetobacter baumannii around London[J]. Int J Antimicrob Agents, 2010, 35 (1):19-24.
[5]张哲,蒋晓飞,吕元. 鲍氏不动杆菌耐药性与β-内酰胺酶基因型研究[J].中华医院感染学杂志, 2007, 17(10):1189-1192.
[6]黄娟,覃金爱,黄春芳, 郭世辉.2003-2005 年医院感染不动杆菌属耐药调查分析[J].中华医院感染学杂志,2009,19(1):99-101.
[7]朱志斌,雷鸣.鲍曼不动杆菌的医院感染分布及耐药性研究[J].实用预防医学, 2008, 15(1):219-221.
[8]汪复,朱德妹,胡付品, 阮斐怡, 倪语星, 孙景勇,等.2007年中国 CHINET细菌耐药性监测[J].中国抗生素感染与化疗杂志,2008, 8(5):325-333.

PDF(960 KB)

Accesses

Citation

Detail

Sections
Recommended

/